Market revenue in 2023 | USD 66.1 million |
Market revenue in 2030 | USD 118.5 million |
Growth rate | 8.7% (CAGR from 2023 to 2030) |
Largest segment | Small molecule |
Fastest growing segment | Large Molecule |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Small Molecule, Large Molecule |
Key market players worldwide | Thermo Fisher Scientific Inc, Icon PLC, Charles River Laboratories International Inc, Labcorp Holdings Inc, IQVIA Holdings Inc, Syneos Health, SGS AG, Intertek Group PLC, Pace Analytical Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioanalytical testing services market will help companies and investors design strategic landscapes.
Small molecule was the largest segment with a revenue share of 54.01% in 2023. Horizon Databook has segmented the Brazil bioanalytical testing services market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2018 to 2030.
The robust growth & development in biologics and the growing pharmaceutical market are expected to encourage bioanalytical testing services. Increasing demand for generic drugs in the country exhibits higher possibilities for bioanalytical testing services.
The rising competition for drug development and approval is anticipated to increase the demand for bioanalytical testing services. According to the data published by International Trade Administration in March 2022, the sale of drugs in Brazil accounted for USD 16.37 billion in revenue in 2022.
In addition, membership of Brazil in the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) has resulted in the implementation of more regulatory policies regarding the release of drug products.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into Brazil bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account